168 related articles for article (PubMed ID: 37687086)
21. Sestrin-3 modulation is essential for therapeutic efficacy of cucurbitacin B in lung cancer cells.
Khan N; Jajeh F; Khan MI; Mukhtar E; Shabana SM; Mukhtar H
Carcinogenesis; 2017 Feb; 38(2):184-195. PubMed ID: 27881463
[TBL] [Abstract][Full Text] [Related]
22. Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Kim M; Kim S; Yim J; Keam B; Kim TM; Jeon YK; Kim DW; Heo DS
Cancer Res Treat; 2023 Oct; 55(4):1134-1143. PubMed ID: 37218137
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
[TBL] [Abstract][Full Text] [Related]
24. Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact.
Weiman S; Dahesh S; Carlin AF; Varki A; Nizet V; Lewis AL
Glycobiology; 2009 Nov; 19(11):1204-13. PubMed ID: 19643844
[TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
26. The group B streptococcal sialic acid O-acetyltransferase is encoded by neuD, a conserved component of bacterial sialic acid biosynthetic gene clusters.
Lewis AL; Hensler ME; Varki A; Nizet V
J Biol Chem; 2006 Apr; 281(16):11186-92. PubMed ID: 16490781
[TBL] [Abstract][Full Text] [Related]
27. STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers.
Chang YF; Lim KH; Chiang YW; Sie ZL; Chang J; Ho AS; Cheng CC
BMC Cancer; 2019 Oct; 19(1):959. PubMed ID: 31619200
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors.
Kuwai T; Nakamura T; Sasaki T; Kim SJ; Fan D; Villares GJ; Zigler M; Wang H; Bar-Eli M; Kerbel RS; Fidler IJ
Neoplasia; 2008 May; 10(5):489-500. PubMed ID: 18472966
[TBL] [Abstract][Full Text] [Related]
29. Cucurbitacin IIb induces apoptosis and cell cycle arrest through regulating EGFR/MAPK pathway.
Liang Y; Zhang T; Ren L; Jing S; Li Z; Zuo P; Li T; Wang Y; Zhang J; Wei Z
Environ Toxicol Pharmacol; 2021 Jan; 81():103542. PubMed ID: 33161110
[TBL] [Abstract][Full Text] [Related]
30. Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib.
Amri J; Molaee N; Baazm M; Karami H
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2781-2787. PubMed ID: 31554377
[TBL] [Abstract][Full Text] [Related]
31. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
32. 9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate.
Baumann AM; Bakkers MJ; Buettner FF; Hartmann M; Grove M; Langereis MA; de Groot RJ; Mühlenhoff M
Nat Commun; 2015 Jul; 6():7673. PubMed ID: 26169044
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.
Ciardiello F; Bianco R; Caputo R; Caputo R; Damiano V; Troiani T; Melisi D; De Vita F; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2004 Jan; 10(2):784-93. PubMed ID: 14760102
[TBL] [Abstract][Full Text] [Related]
34. EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage.
Kuroda S; Tam J; Roth JA; Sokolov K; Ramesh R
Int J Nanomedicine; 2014; 9():3825-39. PubMed ID: 25143731
[TBL] [Abstract][Full Text] [Related]
35. Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas.
Gong Y; Somwar R; Politi K; Balak M; Chmielecki J; Jiang X; Pao W
PLoS Med; 2007 Oct; 4(10):e294. PubMed ID: 17927446
[TBL] [Abstract][Full Text] [Related]
36. Novel irreversible EGFR tyrosine kinase inhibitor 324674 sensitizes human colon carcinoma HT29 and SW480 cells to apoptosis by blocking the EGFR pathway.
Yu Z; Cui B; Jin Y; Chen H; Wang X
Biochem Biophys Res Commun; 2011 Aug; 411(4):751-6. PubMed ID: 21782788
[TBL] [Abstract][Full Text] [Related]
37. NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus.
Lewis AL; Cao H; Patel SK; Diaz S; Ryan W; Carlin AF; Thon V; Lewis WG; Varki A; Chen X; Nizet V
J Biol Chem; 2007 Sep; 282(38):27562-71. PubMed ID: 17646166
[TBL] [Abstract][Full Text] [Related]
38. A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy.
McLaughlin RP; He J; van der Noord VE; Redel J; Foekens JA; Martens JWM; Smid M; Zhang Y; van de Water B
Breast Cancer Res; 2019 Jul; 21(1):77. PubMed ID: 31262335
[TBL] [Abstract][Full Text] [Related]
39. Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death.
Chen P; Huang HP; Wang Y; Jin J; Long WG; Chen K; Zhao XH; Chen CG; Li J
J Exp Clin Cancer Res; 2019 Jun; 38(1):254. PubMed ID: 31196210
[TBL] [Abstract][Full Text] [Related]
40. Six first-line tyrosine kinase inhibitors reveal novel inhibition potential for the EGFR S768I mutation.
Wang Y; Liu Q; Chu C; Li L; Wang Z; Liu Q; Wu G; Wei X; An L; Ma J
Toxicol Appl Pharmacol; 2023 Feb; 461():116385. PubMed ID: 36682591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
